Securing Standard Half Life Recombinant Anti Haemophilic Factor VIII for Kerala Healthcare

Work Description - E-tender For The Procurement Of Standard Half Life Recombinant Anti Haemophilic Factor Viii

The Kerala Medical Services Corporation Ltd (KMSCL), a State Government undertaking, invites qualified and experienced bidders to participate in an e-Tender for the procurement of **Standard Half Life Recombinant Anti Haemophilic Factor VIII**. This open tender, bearing reference number KMSCL/ED/ HAEM/RT/2026/018, seeks to secure essential medical supplies to support healthcare initiatives for a period of 365 days. The tender process commenced with its e-publication on 04-Jul-2026 at 05:15 PM. Interested parties can download tender documents and submit their bids online from 04-Jul-2026 05:15 PM until the submission deadline of 14-Jul-2026 05:00 PM. Technical and financial bids, comprising two covers, will be opened on 16-Jul-2026 at 11:00 AM at Thiruvananthapuram. A Tender Fee of ₹29,795 (exemption allowed) and an Earnest Money Deposit (EMD) of ₹50,000 (exemption allowed) are required. Bids will remain valid for 180 days from the opening date. Detailed technical specifications, eligibility criteria including requirements for manufacturing/import licenses, GMP certificates, annual turnover statements, and other essential documentation are outlined in the comprehensive tender documents available for download. The Managing Director of Kerala Medical Services Corporation Ltd, located at Thycaud, Thiruvananthapuram, serves as the Tender Inviting Authority.